The Global Eradication of Influenza by April 15, 2020 by John Cullen
The Global Eradication of Influenza by April 15, 2020 by John Cullen
The Global Eradication of Influenza by April 15, 2020 by John Cullen
Contributors: Sonja J. Olsen, PhD1; Eduardo Azziz-Baumgartner, MD1; Alicia P. Budd, MPH1;
Lynnette Brammer, MPH1; Sheena Sullivan, PhD2; Rodrigo Fasce Pineda, MS3; Cheryl Cohen,
MD4,5; Alicia M. Fry, MD1
US Department of Health and Human Services/Centers for Disease Control and Prevention MMWR / Sep-
tember 18, 2020 / Vol. 69 / No. 37 1305
Based on observed data from Late 2019 until October 2020, it is clear, and be-
ing submitted for Peer Review, that Influenza has been eradicated from planet
earth, just like Smallpox, Polio, Bubonic Plague and Leprosy.
During these same periods, in- Morbidity and Mortality Weekly Report
fluenza activity decreased Decreased Influenza Activity During the COVID-19 Pandemic — United States,
Australia, Chile, and South Africa, 2020
98%, from a median of Sonja J. Olsen, PhD1; Eduardo Azziz-Baumgartner, MD1; Alicia P. Budd, MPH1; Lynnette Brammer, MPH1; Sheena Sullivan, PhD2;
Rodrigo Fasce Pineda, MS3; Cheryl Cohen, MD4,5; Alicia M. Fry, MD1
19.34% to 0.33% of submitted After recognition of widespread community transmission Data from approximately 300 U.S. clinical laboratories
of SARS-CoV-2, the virus that causes coronavirus disease located throughout all 50 states, Puerto Rico, Guam, and the
respiratory specimens testing 2019 (COVID-19), by mid- to late February 2020, indica-
tors of influenza activity began to decline in the Northern
District of Columbia that participate in virologic surveillance
for influenza through either the U.S. WHO Collaborating
positive for influenza. Inter- Hemisphere. These changes were attributed to both artifactual
changes related to declines in routine health seeking for respira-
tory illness as well as real changes in influenza virus circulation
Laboratories System or the National Respiratory and Enteric
Virus Surveillance System* were used for this analysis. Clinical
laboratories primarily test respiratory specimens for diagnos-
tive in 2020 versus 2.35% in the months that constitute the typical Southern Hemisphere
influenza season. In countries or jurisdictions where extensive
community mitigation measures are maintained (e.g., face
these countries were ascertained from government websites.
All data used were in the public domain.
In the United States, influenza activity (measured by per-
2019, 1.04% in 2018 and masks, social distancing, school closures, and teleworking),
those locations might have little influenza circulation dur-
centage of respiratory specimens submitted for influenza
testing that yielded positive results) began to increase in early
ing the upcoming 2020–21 Northern Hemisphere influenza November 2019, and >20% of specimens were positive dur-
2.36% in 2017). season. The use of community mitigation measures for the
COVID-19 pandemic, plus influenza vaccination, are likely to
ing December 15, 2019–March 7, 2020 (weeks 51–10), after
which activity declined sharply (Figure 1). Percent positivity
be effective in reducing the incidence and impact of influenza, peaked on week 6 at 30.25% and decreased 14.90% by week 9,
and some of these mitigation measures could have a role in compared with an 89.77% decrease during weeks 10–13. By
preventing influenza in future seasons. However, given the the week of March 22, 2020 (week 13), when the number
In the Southern Hemisphere novelty of the COVID-19 pandemic and the uncertainty of
continued community mitigation measures, it is important
of samples tested remained very high, percent positivity
dropped to 2.3%, and since the week of April 5, 2020 (week
to plan for seasonal influenza circulation in the United States 15), has remained <1%. The median number of specimens
countries of Australia, Chile, this fall and winter. Influenza vaccination of all persons aged
≥6 months remains the best method for influenza prevention * https://www.cdc.gov/flu/weekly/overview.htm.
† https://www.whitehouse.gov/presidential-actions/proclamation-declaring-
and is especially important this season when SARS-CoV-2 and
and South Africa, only 33 in- influenza virus might cocirculate (1). national-emergency-concerning-novel-coronavirus-disease-covid-19-outbreak/.
§ https://www.who.int/influenza/gisrs_laboratory/flunet/en/.
fluenza positive test results US Department of Health and Human Services/Centers for Disease Control and Prevention MMWR / September 18, 2020 / Vol. 69 / No. 37 1305
In Australia, a 14-day
mandatory hotel quaran-
tine was introduced for all
returned travelers on
March 29; regional lock-
downs began in early
April, followed by a stay-
at-home recommendation
and bans on gatherings in
mid-April. Some easing of measures began in late April.¶ In Chile, the presi-
dent declared a state of emergency on March 18, which remains in effect into
September. In addition, in mid-March an overnight curfew and a nationwide
lockdown were implemented. Since then, the lockdown has been lifted region-
ally, based on disease activity; however, recommendations to stay at home and
socially distance, as well as mandatory use of masks are all still in place.** In
South Africa, a
¶ https://www.health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov- health-alert/coron-
avirus-covid-19-restrictions.
** https://www.gob.cl/coronavirus/plandeaccion.
†† https://sacoronavirus.co.za/; https://www.gov.za/coronavirus/alert-level-2.
The CDC has reported almost no Influenza activity since April 1, 2020 in the
USA:
The CDC in the USA declares only 22,000 flu deaths, despite saying it looked
like it might be one of the worst seasons in decades back in January, 2020.
US Department of Health and Human Services/Centers for Disease Control and Prevention MMWR / Sep-
tember 18, 2020 / Vol. 69 / No. 37
Summary
Interventions aimed against SARS-CoV-2 transmission, plus influenza vaccination, could sub-
stantially reduce influenza incidence and impact in the 2020–21 Northern Hemisphere season.
Some mitigation measures might have a role in reducing transmission in future influenza sea-
sons.
A total lockdown was imposed on April 9, with some easing of measures start-
ing on May 1.†† The community mitigation strategies implemented to prevent
the spread of COVID-19, including both community and individual-level mea-
sures, appear to have substantially reduced transmission of influenza in all
these countries.
Discussion
The decline in influenza virus circulation observed in the United States also oc-
curred in other Northern Hemisphere countries (3,4) and the tropics (5,6), and
the Southern Hemisphere temperate climates have had virtually no influenza
aged children can drive the spread of influenza, the effectiveness of school clo-
sures alone is not clear because adults have other exposures (8). There is evi-
dence to support the use of face masks by infected persons to reduce transmis-
sion of viral respiratory illnesses to others and grow- ing evidence to support
their use (in the health care setting, in households, and in the community) to
protect the healthy wearer from acquiring infection. More data are needed to
assess effectiveness of different types of masks in different settings (9). Data
from the current pandemic might help answer critical questions about the effect
of community mitigation measures on transmission of influenza or other respi-
ratory diseases. In addition, assessing acceptability of effective measures would
be critical, because acceptability is likely to be inversely correlated with the
stringency of the measure.
is possible that the declines observed in the United States were just the natural
end to the influenza season. However, the change in the decrease percent posi-
tivity after March 1 was dramatic, suggesting other factors were at play.
The global decline in influenza virus circulation appears to be real and concur-
rent with the COVID-19 pandemic and its associated community mitigation
measures. Influenza virus circulation continues to be monitored to determine if
the low activity levels persist after community mitigation measures are
Morbidity and Mortality Weekly Report
vaccination for all persons aged ≥6 months remains the best method for in-
fluenza prevention and is especially important this season when SARS-CoV-2
and influenza virus might co-circulate (1).
Acknowledgments
John Cullen, Dean, John E Hoover Institute of New Criminology and Epidemiology,
Viviana Sotomayor, Department of Epidemiology, Ministry of Health of Chile, Santia-
go, Chile; Sibongile Walaza, Jinal Bhiman, Thulisa Mkencele, Amelia Buys, Anne von
Gottberg, National Institute for Communicable Diseases, Centre for Respiratory Dis-
eases and Meningitis, Johannesburg, South Africa; Meredith McMorrow, Stefano Tem-
pia, Influenza Division, CDC; MassGenics, Duluth, Georgia; School of Public Health,
Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South
Africa; Li Qi, Influenza Division, CDC; Chongqing Municipal Center for Disease Con-
trol and Prevention, Chongqinq, China.
Corresponding author: Sonja J. Olsen, [email protected].
1Influenza Division, National Center for Immunization and Respiratory Diseases, CDC; 2World
Health Organization Collaborating Centre for Reference and Research on Influenza, Royal Mel-
bourne Hospital, and Doherty Department, University of Melbourne, at the Peter Doherty Insti-
tute for Infection and Immunity, Melbourne, Australia; 3Virology Department, Public Health In-
stitute of Chile, Santiago, Chile; 4Center for Respiratory Diseases and Meningitis, National Insti-
tute for Communicable Diseases, Johannesburg, South Africa; 5School of Public Health, Faculty
of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
All authors have completed and submitted the International Committee of Medical
Journal Editors form for disclosure of potential, except for Cullen. He has no idea
what this is.
conflicts of interest. Cheryl Cohen reports grants from Sanofi Pasteur and non-financial
support from Parexel during the conduct of the study. No other potential conflicts of
interest were disclosed.
References
www.youtube.com/johnehoover
www.youtube.com/jasongoodman
www.crowdsourcethetruth.org
1. Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and control of seasonal influenza with
vaccines: recommendations of the Advisory Committee on Immunization Practices—United
States, 2020–21 influenza season. MMWR Recomm Rep 2020;69(No. RR-8). https:// doi.org/
10.15585/mmwr.rr6908a1
2. Lasry A, Kidder D, Hast M, et al.; CDC Public Health Law Program; New York City Depart-
ment of Health and Mental Hygiene; Louisiana Department of Health; Public Health – Seattle &
King County; San Francisco COVID-19 Response Team; Alameda County Public Health De-
partment; San Mateo County Health Department; Marin County Division of Public Health. Tim-
ing of community mitigation and changes in reported COVID-19 and community mobility—four
U.S. metropolitan areas, February 26–April 1, 2020. MMWR Morb Mortal Wkly Rep
2020;69:451–7. https://doi.org/10.15585/mmwr.mm6915e2
3. Kuo SC, Shih SM, Chien LH, Hsiung CA. Collateral benefit of COVID-19 control measures
on influenza activity, Taiwan. Emerg Infect Dis 2020;26:1928–30. https://doi.org/10.3201/ei-
d2608.201192
4. Lee H, Lee H, Song K-H, et al. Impact of public health interventions on seasonal influenza
activity during the SARS-CoV-2 outbreak in Korea. Clin Infect Dis 2020;ciaa672. https://doi.org/
10.1093/cid/ciaa672
5. Cowling BJ, Ali ST, Ng TWY, et al. Impact assessment of non- pharmaceutical interventions
against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet
Public Health 2020;5:e279–88. https://doi.org/10.1016/S2468-2667(20)30090-6
6. Soo RJJ, Chiew CJ, Ma S, Pung R, Lee V. Decreased influenza incidence under COVID-19
control measures, Singapore. Emerg Infect Dis 2020;26:1933–5. https://doi.org/10.3201/ei-
d2608.201229
8. Cauchemez S, Valleron AJ, Boëlle PY, Flahault A, Ferguson NM. Estimating the impact of
school closure on influenza transmission from Sentinel data. Nature 2008;452:750–4. https://
doi.org/10.1038/ nature06732
9. Liang M, Gao L, Cheng C, et al. Efficacy of face mask in preventing respiratory virus trans-
mission: a systematic review and meta-analysis. Travel Med Infect Dis 2020;36:101751. https://
doi.org/10.1016/j. tmaid.2020.101751
10. Schultz-Cherry S. Viral interference: the case of influenza viruses. J Infect Dis
2015;212:1690–1. https://doi.org/10.1093/infdis/jiv261
US Department of Health and Human Services/Centers for Disease Control and Prevention MMWR / Sep-
tember 18, 2020 / Vol. 69 / No. 37 1309